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ABSTRACT
Objective: The involvement of the genital mycoplasmas Ureaplasma urealyticum and Mycoplasma
hominis in complications ofpregnancy has remained controversial especially because these microor-
ganisms are frequent colonizers of the lower genital tract. Recovery of bacteria from the placenta
appears to be the sole technique to represent a true infection and not vaginal contamination.
Therefore, we investigated the presence of genital mycoplasmas, aerobic and anaerobic bacteria,
and fungi in human placentas and evaluated their association with morbidity and mortality of
pregnancy.
Methods: We cultured placentas from 82 women with complicated pregnancies. One hundred
placentas from women with uncomplicated pregnancies were evaluated as controls. When possible,
placentas were examined histologically for presence of chorioamnionitis.
Results: Microorganisms were recovered from 52% of the placentas of complicated pregnancies
and U. urealyticum was the microorganism isolated most frequently from the placenta.A significant
association between positive mycoplasma culture ofthe placenta and complication ofpregnancy was
found, and chorioamnionitis was positively related to isolation ofmycoplasmas.
Conclusions: These data suggest that genital mycoplasmas are able to infect the human placenta
where they can cause chorioamnionitis. This infection of the placenta by genital mycoplasmas is
related to preterm birth and fatal outcome ofpregnancy. (C) 1994 Wiley-Liss, Inc.
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he genital mycoplasmas Mycoplasma hominis and
Ureaplasma urealyticum are colonizers of the
female lower genital tract.
1-3 These organisms have
been associated with various obstetrical complica-
tions: mortality (early spontaneous abortion, late
abortion, stillbirth, neonatal death)and morbidity
(premature rupture of membranes, preterm birth,
low birth weight).
4 The involvement ofM. homin#
and U. urealyticum in these pathologies has been
determined by isolation of these bacteria in the
female lower and upper genital tracts (vagina,
uterus, and amniotic fluid).
5-9 However, the high
rate (10-60%) of genital colonization in the female
population makes it difficult to appreciate the real
pathogenic role of these 2 genital mycoplasmas in
pregnancy. 3’4’9 A study protocol was therefore de-
signed to correlate isolation of these microorgan-
isms directly from the placenta with morbidity and
mortality of pregnancy. A sampling of the endo-
metrial portion of the placenta from placentas of
wornen with complicated pregnancies was cultured
for genital mycoplasmas. A control group of pla-
centas from uncomplicated pregnancies was simi-
larly evaluated. All placentas were also examined
for other bacterial and fungal pathogens. Placentas
were examined histologically when possible and the
patients’ charts were reviewed to evaluate specific
clinical parameters.
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TABLE I. Complicated pregnancies: maternal and
fetal abnormalities indicating placenta sampling
(abnormality could be associated)
Maternal abnormalities N Fetal abnormalities N
Maternal fever 40 Spontaneous abortion 12
Clinical evidence of infection 10 Stillbirth 6
Premature rupture of membranes 14 Preterm birth 13
Preterm labor 18 Low birth weight 4
SUBJECTS AND METHODS
Women were enrolled between November 1991
and November 1992 from the Unit of Gynecology
and Obstetrics of the University Hospital of
Marseille, France. All women admitted to the unit
were screened for eligibility. Patients were selected
as follows: women with documented uterine or fetal
anomalies, placenta previa, abruptio placentae, or
cervical cerclage were excluded from the study and
women presenting with at least one maternal or
fetal abnormality listed in Table were included in
the study. The placentas of these subjects were sub-
mitted to the laboratory for microbiological exami-
nation and culture. Placentas from women with
uncomplicated pregnancies and none of the fetal or
maternal abnormalities listed in Table were eval-
uated as controls. Samples of the maternal surface
of the placenta were obtained with a sterile surgical
blade by slicing a 1.0 1.0 1.0 cm portion of
the depth of the placenta. The samples were ground
with a sterile tissue grinder and examined follow-
ing Gram staining. Aerobic and anaerobic cultures
for bacteria and fungi were made. Mycoplasmas
were cultured in both liquid and agar media. Bac-
teria and fungi were identified according to the
technique of Balows et al.
10 For culture of myco-
plasmas, the placental tissue suspension was trans-
ferred onto a Mycofast identification strip (Groupe
Stago, International Mycoplasma, Signes, France)
and selective A-7 agar medium (Groupe Stago,
International Mycoplasma) following the manufac-
turers’ instructions. 11’12 Both the Mycofast strip
and A-7 plates were incubated for 7 days at 37C in
a COz atmosphere and were examined daily for the
presence of U. urealyticum and/or M. homin#. Cul-
ture confirmation and numeration of mycoplasma
were based on the detection of the color changes in
the Mycofast identification strip and on the colonial
morphology in A-7 agar. All placentas were cul-
tured on the same day of delivery without knowl-
edge of the subject’s status. When the attending
physician requested it, the placenta was examined
histologically without knowledge of the results of
cultures or the status of the subject. The reasons for
histopathological examination of the placenta in-
cluded stillbirth, neonatal death, and complications
of pregnancy, labor, or delivery. Histological
chorioamnionitis was defined as the demonstration
of inflammatory cells, predominantly neutrophils,
in the chorion and amnion.
13
The medical records of all women were re-
viewed. Gestational age was estimated from the
date of the mother’s last menstruation, fundal
height, and ultrasonography. Prematurity was de-
fined as a gestational age of <35 weeks. Fatal out-
come of pregnancy was defined as mortality due to
early or late abortion, death in utero, or stillbirth.
The distribution of the culture results of the
microorganisms among the study groups was ex-
amined. A X
2 test was used to evaluate the equality
of proportions of positive cultures and presence of
chorioamnionitis in the study groups and to corre-
late ratios of positive culture, chorioamnionitis, pre-
maturity, and fatal outcome of pregnancy.
RESULTS
In all, 82 placentas were obtained from women
with complicated pregnancies and 100 placentas
from women with none of the fetal or maternal
abnormalities listed in Table were used as con-
trols.
The recovery of U. urealyticum, M. hominis,
and other bacteria from the placenta in both groups
is shown in Table 2. Microorganisms were recov-
ered from 43 (52%) of the 82 placentas from com-
plicated pregnancies. Twenty-two placentas (27%)
contained genital mycoplasmas and 21 placentas
(25%) other bacteria. Only 4 placentas (4%) of the
control group grew microorganisms. The variation
of the isolation rate of microorganisms among the
study group and the control group was statistically
significant (P < 10-8). In the study group, U.
urealyticum was the microorganism isolated most
frequently from the placenta (24%). These data
show a significant association between positive my-
coplasma cultures of the placenta and complications
of pregnancy (P < 10-6).
The results of the histopathological examination
of the placenta are shown in Table 3. In all, 61 of
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(N 82) (N 100)
N % N % P
Genital mycoplasmas
Ureaplasma urealyticum 20 24 < 10
-6
Mycoplasma hominis 2 2.4
Facultative bacteria
Group B Streptococcus 3 3.7
Viridans streptococci 3 3.7
Enterococcus 3 3.7
Escherichia coli 5 6
Staphylococcus aureus 1.2 < 10-s
Anaerobic bacteria
Peptostreptococcus 4 4.9
Clostridium 1.2 2 2
Yeast
Candida albicans 1.2
Total microorganisms 43 52 4 4 < 10
-8
Sterile 39 48 96 96
aU. urealyticum was associated in placenta ofthe study group with group
B streptococci and in another placenta with E. coil
TABLE 3. Association of bacterial isolates from the





Ureaplasma urealyticum I/I 6 69
Mycoplasma hominis
Facultative bacteria
Group B Streptococcus 2/2 I00
Viridans streptococci 3/3 100
Enterococcus 2/3 66
Escherichia coli 4/5 80




Total microorganisms 25/33 76
Sterile 9/28 32
the 82 placentas from complicated pregnancies were
examined histopathologically. Of these, 34 placen-
tas (56%) showed histopathological chorioamnioni-
tis. Chorioamnionitis was seen in 69% of the 16
placentas from which mycoplasmas were isolated;
32% of the sterile placentas of the study group
showed inflammation. This difference in occur-
rence of chorioamnionitis was significant
(P < 0.002). When comparing the sterile placen-
tas, we noted that recovery of genital mycoplasmas
or other bacteria of the placenta was significantly
related to preterm birth and mortality of pregnancy
(Table 4). In the group of placentas growing geni-
tal mycoplasmas, 27% were associated with pre-
term birth (P < 0.03) and 45% to fatal outcome
of the pregnancy (P < 10-4). In the group of pla-
centas infected with bacteria other than genital
mycoplasmas, 24% were associated with preterm
birth (_P < 0.05) and 33% with fatal outcome of
pregnancy (P < 0.002). Recovery of genital my-
coplasmas and other bacteria was significantly re-
lated to preterm birth and mortality of pregnancy
(Table 4).
DISCUSSION
The involvement of the genital mycoplasmas U.
urealyticum and M. hominis in mortality and mor-
bidity of pregnancy was initially suggested by isola-
tion of these bacteria in the female lower and upper
genital tracts (vagina, uterus, amniotic fluid, and
endometrium)
5-9 or by serological diagnosis.
14,15
However, the role of genital mycoplasma infection
in complications ofpregnancy has remained contro-
versial especially because these microorganisms fre-
quently colonize the lower genital tract of pregnant
women who are not ill and who give birth to nor-
mal, healthy infants. In fact, the high prevalence of
genital colonization in the female population, which
ranges from 10 to 60%, makes it difficult to accept
that in some patients mycoplasmas are pathogenic,
while in other there is no evidence of infection.
2 A
recent review on the role of U. urealyticum in pre-
mature birth demonstrated that U. urealyticum in
the lower genital tract is not directly associated with
preterm birth, as preterm birth is related to a vari-
ety ofrisk factors for prematurity (black race, young
maternal age, low educational level, low income,
smoking during pregnancy, history of marijuana
and/or cocaine use, and separate, single marital
status). The authors conclude that these factors may
be interdependent and that no consistent cause-and-
effect relationship exists between the presence of U.
urealyticum in the lower genital tract of the mother
and prematurity.
9 This opinion is supported by the
findings of 2 studies in which erythromycin was
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TABLE 4. Relationship of preterm birth and fatal outcome (abortion, intrauterine decease, stillbirth) of the
pregnancy to bacterial infection of the placenta
Placentas growing Placentas growing bacteria
genital mycoplasmas other than mycoplasmas Sterile placentas Total
(N 22) (N 21) (N 39) (N 82)
N % N % N % N %
Preterm birth 6 27 S 24 2 5 13 16
Fatal outcome 10 45 7 33 2.5 18 22
used to treat women with genital colonization by
mycoplasmas. In these 2 studies, it was demon-
strated that erythromycin treatment in women with
U. urealyticum in the lower genital tract had virtu-
ally no impact upon low birth weight or prematu-
rity. 6’ 17 As there are case reports implicating U.
urealyticum in clinical amnionitis, investigators tried
to correlate the presence of mycoplasmas in the
amniotic fluid with the morbidity ofpregnancy. 7’8
However, mycoplasmas are present in 50% of am-
niotic fluid samples from both women with intra-
amniotic infection and asymptomatic control women
and U. urealyticum does not appear to be associated
with clinically evident intra-amniotic mycoplasmal
infection.
19
In fact, the recovery of bacteria from the pla-
centa appears to be the sole technique to represent a
true infection and not vaginal contamination,
9 as
bacteria from the typical vaginal flora are almost
never recovered from placental specimens. Fur-
thermore, the relationship between infection of the
placenta and prematurity has been shown to be
independent of the duration of labor, the presence
of ruptured membranes, or the duration of rup-
tured membranes,z These findings suggest that
infection occurs before labor and is not a result of
prolonged labor or rupture of membranes. So far,
only 7 studies have examined the relationship be-
tween colonization of the placenta and outcome of
pregnancy. Naessens et al.
2 cultured placentas for
U. urealyticum but notM. homin# from 253 women
and found no significant difference in the birth
weight of infants whose placentas were colonized.
Two other studies showed that the presence of U.
urealyticum in the placenta was not related to low
birth weight or prematurity. 22’23 Embree et al.
24
cultured placentas from a group of 446 "high-risk"
pregnancies and 108 unselected deliveries of nor-
mal full-term infants and found an association of
the isolation of U. urealyticum with prematurity,
lower birth weight, and intrauterine growth retar-
dation. Kundsin et al.
2s confirmed those data in a
prospective study by isolating mycoplasmas more
frequently from the placentas of infants who died in
the perinatal period and from the placentas of those
neonates admitted to the intensive case unit than
from matched controls. Hillier et al.
2 related both
the isolation of U. urealyticum alone or with other
bacteria and the isolation of bacteria without U.
urealyticum to premature delivery. In these latter 3
studies, U. urealyticum was isolated from the chori-
oamnion of 24-47% of patients who delivered low
birth weight, premature infants and from 9-19%
of patients who delivered at term. The frequency of
isolation of U. urealyticum from the chorioamnion
was significantly higher in those who delivered
prematurely compared with those who delivered at
term in these 3 studies.
As for the role of mycoplasmas in the fatal out-
come of pregnancy, the st reports on the isolation
of genital mycoplasmas from stillbirth were based
on individual cases in which these organisms were
isolated from fetal lungs, brain, heart, and vis-
cera
26-3 and on 2 studies in which U. urealyticum
was isolated more frequently from the products of
early abortions and mid-trimester fetal losses than
from products of induced abortions.’2 Embree
et al.
24 isolated U. urealyticum more frequently
from placentas of aborted fetuses than from con-
trols. In another study of 33 perinatal death and 31
random cases of normal term deliveries, Quinn
et al. isolated genital mycoplasmas significantly
more often from cases in which death of the fetus
could not be attributed to a known anatomic or
morphologic cause than from controls. Unfortu-
nately, these authors combined their culture data
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with serological results and cases were considered
positive if they were serologically positive even
though they were culture negative.
Histological chorioamnionitis has consistently
been related to morbidity and mortality of preg-
nancy. What causes chorioamnionitis is still a con-
troversial subject because of the diversity of micro-
organisms isolated, often of low virulence, and the
concept that non-specific placental inflammation
may occur.
34 As related to the cause of perinatal
death, no morphologic cause could be documented
at autopsy of the fetus in nearly 2/3 of cases and it
was shown that chorioamnionitis occurs in more
than 50% of these stillbirths and early neonatal
deaths. 33’3s Moreover, the rates of histological
chorioamnionitis are 2- to 5-fold higher in patients
who deliver preterm than in those who deliver at
term
2 and a direct relationship exists between the
degrees of prematurity and the prevalence of histo-
logical chorioamnionitis.
13 It was shown that bacte-
ria are recovered from the placenta of 70% of pa-
tients with histological chorioamnionitis but from
only 15-45% of patients without histological chori-
oamnionitis.
36 U. urealyticum was isolated from the
chorioamnion of 38-66% of patients with histolog-
ical chorioamnionitis and from 13-17% of patients
without histological chorioamnionitis. All of these
studies which associated microbiological and histo-
logical examination of placentas revealed an in-
creased prevalence of chorioamnionitis, spontane-
ous abortion, stillbirth, neonatal death, and
perinatal morbidity among women with mycoplas-
mas isolated from the placenta compared with cases
which were culture negative. 2’24’25’35 These stud-
ies suggest that U. urealyticum associated with chori-
oamnionitis may be a major factor in placental in-
fections leading to perinatal morbidity and
mortality. The aim of our study was to determine if
placental infections and particularly infections with
mycoplasmas represent cause of preterm birth
and/or fatal outcome of pregnancy. We studied the
relationship between morbidity (prematurity) and
mortality of pregnancy with both microbiologic
and histologic findings of the placenta. A recent
review of the 7 reports concerning isolation of my-
coplasmas in the placenta suggests that the presence
of U. urealyticum in the chorioamnion is only
weakly associated with prematurity but strongly
associated with histological chorioamnionitis.
9 Our
results demonstrate an association between histolog-
ical chorioamnionitis and the recovery of microor-
ganisms from the placenta. In all, we found that in
the group of complicated pregnancies 76% of the
placentas growing mycoplasmas or other bacteria
showed histological inflammation compared with
32% of the sterile placentas. U. urealyticum was the
microorganism most frequently isolated from the
placentas of complicated pregnancies. A lack of
vaginal contamination was suggested by the absence
ofLactobacillus isolated from the placental cultures.
The presence of U. urealyticum in the chorioam-
nion appears to cause histological chorioamnionitis
in the same manner as the well-known placental
pathogens Escherichia coli and group B Streptococ-
cus. Furthermore, chorioamnionitis and isolation
of specific microorganisms from the placenta are
associated with a significant incidence of prematu-
rity and fatal outcome of pregnancy.
As for prematurity, pregnancies with placentas
harboring genital mycoplasmas or other bacteria
had significantly higher preterm birth rates (27
and 24%, respectively) than complicated pregnan-
cies with sterile placentas (5%). As for fatal out-
come of pregnancy, previous studies showed an
increased incidence ofchorioamnionitis and a higher
isolation rate of U. urealyticum in perinatal deaths
compared with controls, especially among those
with no anatomic cause of death. In our study,
chorioamnionitis was observed in 68% of pregnan-
cies with fatal outcome. We observed a higher rate
of fatal outcome in the group of pregnancies with
placentas growing genital mycoplasmas (45%) than
in the group growing bacteria other than mycoplas-
mas (33%) or in the group of sterile placentas
(2.5%). These results are consistent with the report
of recovery of U. urealyticum from discolored am-
niotic fluid among patients undergoing amniocen-
tesis at 16-20 weeks gestation for genetic evalua-
tion. In this study, patients with U. urealyticum in
the discolored amniotic fluid delivered prematurely
with evidence of severe histological chorioamnion-
itis and fetal U. urealyticum infection. Further-
more, in a bovine model, ureaplasmas that were
experimentally inoculated into the amniotic flud of
pregnant heifers were shown to induce abortion and
premature delivery associated with severe placenti-
tis.37,38
In conclusion, our findings suggest that U. ure-
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alyticum is emerging as an important placental
pathogen. The colonization ofthe placenta with this
microorganism, frequently associated with chorio-
amnionitis, constitutes a major factor in intrauter-
ine infections associated with morbidity and mor-
tality of pregnancy. Unfortunately, no clinically
useful methods to diagnose placental infections be-
fore delivery are available. On the basis of our
results, we recommend that histological and micro-
biological examination of the placenta be done in all
cases ofcomplicated pregnancies. Only in this man-
ner can we better understand the pathogenesis of
placental infections and develop diagnostic and ther-
apeutic tools to improve morbidity and mortality of
these pregnancies.
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